UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): July 16, 2010
Alere
Inc.
(Exact
name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware |
|
001-16789 |
|
04-3565120 |
| (State or other jurisdiction
|
|
(Commission file number)
|
|
(IRS Employer |
| of incorporation)
|
|
|
|
Identification No.) |
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)
Registrant’s telephone number, including area code: (781) 647-3900
Inverness Medical Innovations, Inc.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.142-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events
Alere Inc. (the “Company”) is filing this Current Report on Form 8-K to
provide the legal opinion of Jay McNamara, Esq., the Company’s Senior Counsel, Corporate & Finance,
relating to the Company’s prospectus supplement filed with the SEC on June 30, 2010 (File No.
333-158542).
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| |
|
|
| Exhibit No. |
|
Description |
| |
5.1 |
|
Opinion of Jay McNamara, Esq., Senior Counsel, Corporate & Finance, of the Company |
|
|
|
23.1 |
|
Consent of Jay McNamara, Esq.,
Senior Counsel, Corporate & Finance, of the Company |
|
|
(included in Exhibit 5.1) |